In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma
Desmond Kwok-Po Hau(Hong Kong Baptist University), David Wang-Fun Fong(Hong Kong Baptist University), Raymond Wong(Chinese University of Hong Kong), Kim Hung Lam(Hong Kong Polytechnic University), Roberto Gambari(University of Ferrara), Alexander Kai‐Man Leung(Hong Kong Baptist University), Guo‐Yuan Zhu(Macau University of Science and Technology), Chor‐Hing Cheng(Hong Kong Polytechnic University), Filly Cheung(Hong Kong Polytechnic University), Gregory Cheng(Chinese University of Hong Kong), Kit-Wah Chan(Chinese University of Hong Kong), Sze-Wai Tong(Chinese University of Hong Kong), Fung-Yi Lau(Chinese University of Hong Kong), Wai‐Yeung Wong(Shenzhen Polytechnic University), Chung-Hin Chui(Hong Kong Polytechnic University), Paul B.S. Lai(Chinese University of Hong Kong)
Cited by 53
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
|Proceedings of the National Academy of Sciences|2015|770
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
|British journal of surgery|2020|719